DK164639C - Middel til behandling af inflammationer i oejet samt fremgangsmaade til fremstilling heraf - Google Patents

Middel til behandling af inflammationer i oejet samt fremgangsmaade til fremstilling heraf

Info

Publication number
DK164639C
DK164639C DK176487A DK176487A DK164639C DK 164639 C DK164639 C DK 164639C DK 176487 A DK176487 A DK 176487A DK 176487 A DK176487 A DK 176487A DK 164639 C DK164639 C DK 164639C
Authority
DK
Denmark
Prior art keywords
inflammations
eyes
procedures
preparing
treatment
Prior art date
Application number
DK176487A
Other languages
English (en)
Other versions
DK176487D0 (da
DK164639B (da
DK176487A (da
Inventor
Johann Doulakas
Original Assignee
Dispersa Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6298657&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK164639(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dispersa Ag filed Critical Dispersa Ag
Publication of DK176487D0 publication Critical patent/DK176487D0/da
Publication of DK176487A publication Critical patent/DK176487A/da
Publication of DK164639B publication Critical patent/DK164639B/da
Application granted granted Critical
Publication of DK164639C publication Critical patent/DK164639C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK176487A 1986-04-14 1987-04-07 Middel til behandling af inflammationer i oejet samt fremgangsmaade til fremstilling heraf DK164639C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3612537 1986-04-14
DE3612537A DE3612537C1 (de) 1986-04-14 1986-04-14 Arzneimittel zur Behandlung von Entzuendungen im Auge

Publications (4)

Publication Number Publication Date
DK176487D0 DK176487D0 (da) 1987-04-07
DK176487A DK176487A (da) 1987-10-15
DK164639B DK164639B (da) 1992-07-27
DK164639C true DK164639C (da) 1992-12-21

Family

ID=6298657

Family Applications (1)

Application Number Title Priority Date Filing Date
DK176487A DK164639C (da) 1986-04-14 1987-04-07 Middel til behandling af inflammationer i oejet samt fremgangsmaade til fremstilling heraf

Country Status (12)

Country Link
US (1) US4829088A (da)
EP (1) EP0242328B1 (da)
JP (1) JP2515788B2 (da)
CA (1) CA1286225C (da)
DE (1) DE3612537C1 (da)
DK (1) DK164639C (da)
EG (1) EG18268A (da)
ES (1) ES2038691T4 (da)
GR (1) GR3002659T3 (da)
NO (1) NO174916C (da)
PT (1) PT84669B (da)
ZA (1) ZA872624B (da)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH675537A5 (da) * 1988-03-25 1990-10-15 Ciba Geigy Ag
US4960799A (en) * 1988-09-13 1990-10-02 Ciba-Geigy Corporation Stabilized aqueous solutions of pharmaceutically acceptable salts of ortho-(2,6-dichlorophenyl)-aminophenylacetic acid for opthalmic use
ES2053161T3 (es) * 1989-09-21 1994-07-16 Ciba Vision Ag Composiciones antimicrobianas.
US6117907A (en) * 1993-04-14 2000-09-12 Sher; Neal A. Topical treatment of ocular pain after corneal surgery
US5494817A (en) * 1993-12-06 1996-02-27 Allergan, Inc. Sugar-based protease composition for use with constant-PH borate buffers
US5474985A (en) * 1993-12-22 1995-12-12 The Regents Of The University Of California Preventing and treating elevated intraocular pressure associated with administered or endogenous steroids using non-steroidal cyclooxygenase inhibitors
ES2079320B1 (es) * 1994-05-17 1996-10-16 Cusi Lab Disolucion oftalmica a base de un diclofenaco y tobramicina y sus aplicaciones.
US6309630B1 (en) 1994-05-24 2001-10-30 Insite Vision Incorporated Non-steroidal anti-inflammatory ophthalmic suspensions
US5789169A (en) * 1994-11-03 1998-08-04 Regents Of The University Of California Methods for the diagnosis of glaucoma
US5849879A (en) * 1994-11-03 1998-12-15 The Regents Of The University Of California Methods for the diagnosis of glaucoma
US5606043A (en) 1994-11-03 1997-02-25 The Regents Of The University Of California Methods for the diagnosis of glaucoma
AU690794B2 (en) * 1995-01-20 1998-04-30 Wakamoto Pharmaceutical Co., Ltd. Anti-inflammatory eyedrops
JP3170619B2 (ja) 1995-04-20 2001-05-28 参天製薬株式会社 有機アミンを配合したプラノプロフェン点眼液
US5620970A (en) * 1995-06-05 1997-04-15 Alcon Laboratories, Inc. Topical ophthalmic carbonic anhydrase inhibitor formulations
US5599535A (en) * 1995-06-07 1997-02-04 Regents Of The University Of California Methods for the cyto-protection of the trabecular meshwork
US5674888A (en) * 1995-06-07 1997-10-07 University Of California Method for the treatment of a trabecular meshwork whose cells are subject to inhibition of cell division
US5686488A (en) * 1995-08-25 1997-11-11 Alcon Laboratories, Inc. Polyethoxylated castor oil products as anti-inflammatory agents
US6004949A (en) * 1995-12-27 1999-12-21 Showa Yakuhin Kako Co., Ltd. Aqueous composition containing cromoglycic acid
US5814655A (en) * 1996-11-14 1998-09-29 Insite Vision Incorporated Non-steroidal ophthalmic mixtures
WO1998025649A1 (en) 1996-12-13 1998-06-18 Alcon Laboratories, Inc. Use of low molecular weight amino alcohols in ophthalmic compositions
US6171788B1 (en) 1997-01-28 2001-01-09 The Regents Of The University Of California Methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
US7138511B1 (en) 1997-01-28 2006-11-21 The Regents Of The University Of California Nucleic acids, kits and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
US6475724B1 (en) 1997-01-28 2002-11-05 The Regents Of The University Of California Nucleic acids, kits, and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
US6265444B1 (en) 1997-05-23 2001-07-24 Insite Vision Incorporated Ophthalmic composition
DE19729879C2 (de) 1997-07-11 1999-07-08 Mann Gerhard Chem Pharm Fab Lagerstabile ophthalmische Zusammensetzungen, umfassend Diclofenac und Ofloxacin
JP2006111636A (ja) * 1997-12-26 2006-04-27 Astellas Pharma Inc 徐放性医薬組成物
AU1548001A (en) * 1999-11-24 2001-06-04 Wakamoto Pharmaceutical Co., Ltd. Ophthalmic aqueous preparation
RU2156128C1 (ru) * 2000-01-05 2000-09-20 Гапонюк Петр Яковлевич Глазные капли для лечения воспалительных заболеваний глаз с аллергическими проявлениями
PE20020146A1 (es) * 2000-07-13 2002-03-31 Upjohn Co Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
US20030119000A1 (en) * 2001-11-05 2003-06-26 Jon Polansky Methods to screen and treat individuals with glaucoma or the propensity to develop glaucoma
TW200304812A (en) * 2002-03-08 2003-10-16 Sankyo Co An eye drop containing a tetrazole derivative
US20050119299A1 (en) * 2002-03-08 2005-06-02 Sankyo Company, Limited Ophthalmic solutions containing tetrazole derivatives
JP4524538B2 (ja) * 2002-04-08 2010-08-18 ライオン株式会社 眼科用組成物
US20040224010A1 (en) * 2002-11-15 2004-11-11 Optime Therapeutics, Inc. Ophthalmic liposome compositions and uses thereof
PE20040844A1 (es) 2002-11-26 2004-12-30 Novartis Ag Acidos fenilaceticos y derivados como inhibidores de la cox-2
JP4933897B2 (ja) 2004-11-05 2012-05-16 千寿製薬株式会社 眼内移行性促進水性点眼剤
JP5607291B2 (ja) * 2004-11-24 2014-10-15 メダ ファーマシューティカルズ インコーポレイテッド アゼラスチンを含む組成物およびその使用方法
US20070020330A1 (en) * 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
US8758816B2 (en) * 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
JP5108234B2 (ja) * 2005-02-07 2012-12-26 日本特殊陶業株式会社 マイクロヒータ及びセンサ
US20070254841A1 (en) * 2006-01-25 2007-11-01 Ophthalmic Research Associates, Inc. Formulations and methods for treating dry eye
US20100130580A1 (en) * 2006-01-25 2010-05-27 Aciex Therapeutics, Inc. Formulations and Methods for Treating Dry Eye
US20070212420A1 (en) * 2006-03-10 2007-09-13 Bausch & Lomb Incorporated Pharmaceutical formulations comprising polyanionic materials and zinc-based preservatives
US7829249B2 (en) * 2007-03-05 2010-11-09 Asml Netherlands B.V. Device manufacturing method, computer program and lithographic apparatus
TWI465236B (zh) * 2007-03-13 2014-12-21 參天製藥股份有限公司 含有吡諾克辛之懸浮型水性液劑
WO2008153746A1 (en) * 2007-05-24 2008-12-18 Aciex Therapeutics, Inc. Formulations and methods for treating dry eye
US20130011469A1 (en) 2009-07-23 2013-01-10 U.S. Nutraceuticals, Llc D/B/A Valensa International Krill oil and carotenoid composition, associated method and delivery system
JP5246182B2 (ja) * 2010-02-24 2013-07-24 ライオン株式会社 点眼剤、防腐剤及び防腐力向上剤
JP5299449B2 (ja) * 2011-02-23 2013-09-25 ライオン株式会社 外用剤組成物
JP2013082682A (ja) * 2011-09-29 2013-05-09 Senju Pharmaceut Co Ltd 亜塩素酸塩を含有する水性製剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU185926B (en) * 1979-09-27 1985-04-28 Agostne Kahan Process for preparing water soluble derivatives of non-steroid antiinflammatory compositions and pharmaceutical compositins containing such derivatives
DE3026402A1 (de) * 1980-07-11 1982-02-04 Syntex Corp., Palo Alto, Calif. Die verwendung analgetischer und nicht-hormonaler, entzuendungshemmender mittel bei der behandlung von mikrovaskulaeren erkrankungen
JPS58174309A (ja) * 1982-04-06 1983-10-13 Wakamoto Pharmaceut Co Ltd 消炎点眼剤
JPS58174310A (ja) * 1982-04-06 1983-10-13 Wakamoto Pharmaceut Co Ltd 抗炎症点眼剤

Also Published As

Publication number Publication date
ZA872624B (en) 1987-12-30
GR3002659T3 (en) 1993-01-25
US4829088A (en) 1989-05-09
PT84669B (pt) 1989-11-30
ES2038691T3 (es) 1993-08-01
JP2515788B2 (ja) 1996-07-10
EP0242328B1 (de) 1991-07-24
JPS62242617A (ja) 1987-10-23
NO174916C (no) 1994-08-03
ES2038691T4 (es) 1995-09-01
EP0242328A3 (en) 1988-04-06
EP0242328A2 (de) 1987-10-21
DE3612537C1 (de) 1987-07-16
DK176487D0 (da) 1987-04-07
NO871549D0 (no) 1987-04-13
NO174916B (no) 1994-04-25
DK164639B (da) 1992-07-27
PT84669A (en) 1987-05-01
DK176487A (da) 1987-10-15
NO871549L (no) 1987-10-15
CA1286225C (en) 1991-07-16
EG18268A (en) 1993-02-28

Similar Documents

Publication Publication Date Title
DK164639C (da) Middel til behandling af inflammationer i oejet samt fremgangsmaade til fremstilling heraf
DK157987D0 (da) Stabilisering af kviksoelvholdige konserveringsmidler i oejenmidler
FI90921C (fi) Läpäisevyydeltään aseteltavat silmälasit
DK181488D0 (da) Carbonholdig absorbent og fremgangsmaade til fjernelse af pyrogener oploest i vand samt fremgangsmaade til fremstilling af superrent vand
SG67492G (en) Optical and ophthalmic glasses
ES2021444B3 (es) Perfeccionamientos en las maquinas de esmerilar y biselar los cristales oftalmicos.
NO167357C (no) Kosmetiske preparater for regenerering og hydratisering av hud samt fremgangsmaate for fremstilling av slike preparater.
ES532985A0 (es) Procedimiento de preparar concentrados y nutrimentos proteinicos
DE68917353D1 (de) N-Alkoxyalkylamide von Hydroxysauren und sie enthaltende Hautbehandlungszubereitungen.
DK292586A (da) Dyrknings- og distributionssystem for potteplanter
NO881245L (no) Kosmetisk lysbeskyttelsespreparat samt fremgangsmaate for fremstilling derav.
IT8768072A0 (it) Perfezionamenti in occhiali
DK147088A (da) Middel til behandling af virale infektioner i mennesker
DE3673913D1 (de) Ophthalmische gelzubereitung und verfahren zur behandlung von augeninfektionen.
BR8702065A (pt) Cabelo artificial para implantacao capilar e processo de preparacao do mesmo
DK158989D0 (da) Fremgangsmaade til enzymatisk afhaaring af huder eller skind
FR2544979B3 (fr) Ciseau pour microchirurgie et notamment microchirurgie oculaire
DK87087D0 (da) Mikrobicide midler samt benzensulfonylazoler og fremgangsmaade til deres fremstilling
DK430188D0 (da) Antithrombolisk materiale til medicinsk anvendelse samt fremgangsmaade til fremstilling deraf
DE3765583D1 (de) Oberflaechenbehandlungsmittel und -verfahren.
DK404587A (da) 5-deoxy-5-flourkanamycin b-derivater samt fremgangsmaader til fremstilling deraf
DK157205C (da) Bjaelke samt fremgangsmaade til fremstilling heraf
DK513386A (da) Optisk aktive acyloxazetidinoner samt deres fremstilling og anvendelse
DK490587A (da) Genteknisk fremgangsmaade til fremstilling af lakse-calcitonin samt middel til gennemfoerelse af fremgangsmaaden
KR890002392U (ko) 근시 및 원시용 안경렌즈 가공기